Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid Arthritis. 2020

Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
From the Departments of Orthopaedic Surgery.

OBJECTIVE The aim of this longitudinal study was to examine the clinical significance of soluble lectin-like oxidized low-density lipoprotein receptor 1 (sLOX-1) in patients with rheumatoid arthritis. METHODS We gathered demographic and clinical data for a large rheumatoid arthritis cohort at 3 time points. Blood samples were collected at each time point; the number of samples was 282 cases in 2012, 431 cases in 2013, and 500 cases in 2014. Plasma sLOX-1 was measured by enzyme-linked immunosorbent assay. Correlations between sLOX-1 and clinical data were analyzed. Predictive factors associated with changes in sLOX-1 and rheumatoid factor (RF) were analyzed by multivariate linear regression. RESULTS Plasma sLOX-1 level was significantly correlated with RF titer and other clinical parameters. The longitudinal analyses showed that changes in sLOX-1 were significantly correlated with changes in RF titers and with those at baseline. Multivariate linear regression analysis revealed that changes in RF and baseline RF were predictive factors for changes in sLOX-1. Conversely, the changes in RF were significantly correlated with the changes in sLOX-1 in all years. A stepwise regression analysis showed that the change in sLOX-1 was a predictive factor for the change in RF. CONCLUSIONS The change in sLOX-1 has predictive value for assessing the change in RF, indicating the usefulness of sLOX-1 in clinical practice.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D051127 Scavenger Receptors, Class E A class of oxidized LDL receptors that contain C-type lectin-like extracellular domains. Scavenger Receptors, Class E, Type I,Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1,OLR1 Protein,Oxidized Low-Density Lipoprotein Receptor 1,SR-E Proteins,SR-EI Proteins,Lectin Like Oxidized Low Density Lipoprotein Receptor 1,Oxidized Low Density Lipoprotein Receptor 1,SR EI Proteins

Related Publications

Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
May 2022, European heart journal,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
November 2004, Arthritis and rheumatism,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
July 2013, European journal of clinical investigation,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
July 2008, Journal of lipid research,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
July 2010, Circulation journal : official journal of the Japanese Circulation Society,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
April 2010, Journal of atherosclerosis and thrombosis,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
January 2001, Trends in cardiovascular medicine,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
February 2009, Zhonghua fu chan ke za zhi,
Akinori Okahata, and Hiromu Ito, and Moritoshi Furu, and Masahiro Ishikawa, and Takayuki Fujii, and Motomu Hashimoto, and Masao Tanaka, and Yugo Morita, and Masayuki Azukizawa, and Takuya Tomizawa, and Kohei Doi, and Kohei Nishitani, and Koichi Murata, and Hiroyuki Yoshitomi, and Tsuneyo Mimori, and Shuichi Matsuda
June 2000, Biochemical and biophysical research communications,
Copied contents to your clipboard!